Skip to main content
Clinical Trials/EUCTR2014-003272-23-ES
EUCTR2014-003272-23-ES
Active, not recruiting
Not Applicable

Prospective Pilot Study of the treatment of compression of median nerve neuropathy with Nucleo CMP Forte®.

Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge0 sitesSeptember 9, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carpal Tunnel Syndrome (CTS)
Sponsor
Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge
Status
Active, not recruiting
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 9, 2014
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients between 18 and 80 years old.
  • 2\) Patients clinically and electrophysiological diagnosed with CTS, who won?t require a premature surgical procedure.
  • 3\) Patients able to understand the study objective and able to give the Inform Consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 40
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 10

Exclusion Criteria

  • 1\) Pregnant or breastfeeding woman.
  • 2\) Patients with high probablility os not completing the study requirements according to the investigator criteria.
  • 3\) Patients with dysphagia which won?t allow them to take the study medication.
  • 4\) Patients diagnosed with neuropathy which is causing an axonal degeneration.
  • 5\) Patients with a recent forearm trauma.
  • 6\) Patients participating in antother Clinical Trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials